Haoyisheng Cloud Healthcare Secures Over RMB 1 Billion in Series A Funding to Accelerate Empowerment of China's Primary Care Market

VCBeat (WeChat ID: vcbeat) has learned that Sichuan Good Doctor Cloud Healthcare & Technology Co., Ltd. (hereinafter referred to as “Good Doctor Cloud Health”) recently announced the completion of its Series A financing round, raising over RMB 100 million (equivalent in USD), with OrbiMed as the lead investor. Following this round, Good Doctor Cloud Health will accelerate its expansion and upgrading in the grassroots internet healthcare market, drive innovation, enhancement, and refinement of its marketing and service systems, continuously expand and integrate its business structure, and solidify its core competitiveness.

GOOD DOCTOR CLOUD HEALTH, established in 2015, is committed to empowering primary healthcare institutions from multiple dimensions—including medical laboratory testing, internet hospitals, pharmaceutical supply, and medical education—by building a comprehensive backend platform for internet-based primary healthcare services. Initially, the company’s core business focused on providing third-party medical laboratory testing services, along with supporting cold-chain logistics and medical technical support, to primary healthcare institutions. Dedicated to enhancing the diagnostic capabilities of these institutions, GOOD DOCTOR CLOUD HEALTH has since accumulated over 100,000 active clinic clients, offers more than 1,000 testing items, and achieves a monthly order volume nearing RMB 20 million. Its business coverage extends across nearly 30 provinces and municipalities and over 1,000 districts and counties throughout China.

In recent years, GOOD DOCTOR CLOUD HEALTH has upgraded and integrated its businesses in the research, development, and supply of specialized therapies; training and deployment of medical assistants; e-commerce for pharmaceuticals, medical devices, and consumables; and online medical education, achieving initial scale. In February 2021, GOOD DOCTOR CLOUD HEALTH officially obtained the license for its internet hospital. Thus, centering on its core positioning of serving the primary healthcare market, GOOD DOCTOR CLOUD HEALTH has established a new-type internet diagnosis and treatment service platform and a comprehensive health ecosystem, encompassing Cloud Healthcare (IT technology development), Cloud Laboratory (clinical laboratory services), Nurse’s Home (training and deployment of medical assistants), specialized therapies, pharmaceutical e-commerce, internet hospital (online consultation and diagnosis), and medical education.

Geng Jie, Chairman of GOOD DOCTOR CLOUD HEALTH, stated that the company has basically completed the establishment of customer and customer service teams covering most provinces, cities, counties, townships, and villages across China, forming a complete business loop. With vast market potential in China’s primary healthcare sector, the company will adhere to its core positioning of providing comprehensive services to primary healthcare institutions, uphold the essential nature of medical services, and strive to become the central back-office support system for primary healthcare institutions nationwide. This round of financing will accelerate HIGH DOCTOR CLOUD HEALTH’s high-quality development in market expansion, model innovation, product research and development, and technology application, thereby completing a new phase of strategic layout.

Geng Funeng, Chairman of Good Doctor Pharmaceutical Group, stated that the primary healthcare market is one of the important foundations for the development of Good Doctor Pharmaceutical Group. With over 30 years of development, we have gained a profound understanding of this market. We believe that the primary healthcare market holds tremendous vitality and its demands are far from being fully met. Meanwhile, only by strengthening primary care can we better promote the comprehensive implementation of tiered diagnosis and treatment. GOOD DOCTOR CLOUD HEALTH is committed to better fulfilling its positioning of serving primary healthcare institutions, more accurately grasping industry development trends in the new era, and absorbing industry wisdom, technologies, and products in a more open and rapid manner. Good Doctor Pharmaceutical Group will continue to integrate various resources into GOOD DOCTOR CLOUD HEALTH to facilitate its faster and healthier development.

David Wang, Global Partner at OrbiMed, stated: “OrbiMed has been focused on global healthcare investments for over two decades, with net assets under management exceeding $13 billion. Our team has conducted in-depth research into China’s primary healthcare market and consistently monitors outstanding enterprises that understand the essence of primary care and deliver specialized services. GOOD DOCTOR CLOUD HEALTH has accumulated years of practical experience in China’s primary healthcare sector, possessing a profound understanding of the market, a solid foundation, and a strong brand image. We appreciate its philosophy of fostering the growth of primary healthcare institutions through an integrated online-offline model, which in turn drives its own development. The company’s professionalism and pragmatic approach ensure effective project implementation. Therefore, OrbiMed is committed to collaborating with GOOD DOCTOR CLOUD HEALTH to build a premier platform dedicated to serving China’s primary healthcare market.”